Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.
about
An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment programDoes group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?Research-practice partners assess their first joint projectDisparities in use of mental health and substance abuse services by persons with co-occurring disorders.Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.A psychosocial comparison of New Orleans and Houston crack smokers in the wake of Hurricane KatrinaSocial anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.The relationship between child abuse and negative outcomes among substance users: psychopathology, health, and comorbidities.Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspectiveRandomization in substance abuse clinical trials.Depression's moderation of the effectiveness of intensive case management with substance-dependent women on temporary assistance for needy families: outpatient substance use disorder treatment utilization and outcomes.Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study.Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study.Chronic care management for substance dependence in primary care among patients with co-occurring disorders.Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders.Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity.Drug-abusing offenders with comorbid mental disorders: problem severity, treatment participation, and recidivism.Co-occurring disorders in substance abuse treatment: issues and prospectsTreatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review.Psychiatric symptomatology among individuals in alcohol detoxification treatmentClinical characteristics as a function of referral status among substance users in residential treatmentDual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems.Alcohol use disorders among substance dependent women on Temporary Assistance with Needy Families: more information for diagnostic modifications for DSM-5.Prevalence and Trajectories of Psychiatric Symptoms Among Sober Living House Residents.Characteristics of an outpatient treatment sample by primary substance of abuse.Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults.Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals.Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders.The availability of integrated care in a national sample of therapeutic communities.Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression.Social stress, economic hardship, and psychological distress as predictors of sustained abstinence from substance use after treatment.Depression, anxiety, hopelessness and quality of life in users of cocaine/crack in outpatient treatment.Criminal typology of veterans entering substance abuse treatment.The psychotropic self/imaginary: subjectivity and psychopharmaceutical use among heroin users with co-occurring mental illness.Crack users show high rates of antisocial personality disorder, engagement in illegal activities and other psychosocial problems.Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population.Quality of life, social functioning, family structure, and treatment history associated with crack cocaine use in youth from the general population.Prevalence of substance use and mental distress among patients on waiting lists for substance use disorder treatment.The Affordable Care Act, Substance Use Disorders, and Low-Income Clients: Implications for Social Work.
P2860
Q24635217-CB045821-7CBE-49DF-A958-B11EB6B9DDD2Q33573787-86C1C3D6-4A18-4D19-BFEB-CC82A0D075F8Q33774927-BE57BDFE-635E-4727-963A-269F3B3EA33BQ33784546-7D26A490-20ED-4633-921B-0C0E2693B541Q33792290-F2353A1E-E9F6-4914-A6C6-D52F2990D7E7Q33812999-F835E16A-C5AE-440D-A681-AFD242AFA3CEQ34049058-087B9482-0396-4D0F-8296-BAC240797594Q34051088-3546E853-F445-424E-83BA-41DD5BF7C049Q34235096-E7289FF2-AEE0-4C5B-A643-3332FC113682Q34538521-34DD3C2C-04D8-48F2-A098-B70A83E71583Q34643836-3CAF5846-E0C3-4CC1-A6AD-049BA706DCDFQ34687009-B08795E1-8FD4-4EBC-9364-BFF4936603ADQ34792192-F1DA80F3-F866-4F51-B768-20155BDD958EQ34809049-0A0AFB3C-68D3-4A93-9499-92CBB2E78233Q35131886-801D3C5D-06E1-4A27-913D-EA7B4E7A701DQ35865541-E02418D2-764C-4022-AB19-AB57FE6A09A0Q35892419-02B76F3D-4E7C-43D6-A65E-80ABB6025524Q35942022-A3ED3869-EB0C-47FD-B35D-86B15E52FBA5Q36384556-998F5FAB-E416-42BF-B9E5-E58CAB268105Q36414662-0F877889-6B1B-4F55-9370-20F5402E4BBCQ36442949-471B83F4-DA00-4589-A674-4FAF68B5B4BEQ36626070-40B5AD9A-CCF5-46B4-8F1E-149B0A91EF48Q36674945-9A4B480F-F6A3-4912-A044-D07654C72C38Q36960509-FF0AD003-6A4B-40B0-A43E-553515CD9916Q37022617-ED9AB69E-B1F7-401C-B969-3716ADB2F50FQ37214182-60768741-9541-4655-A756-24CDC093DA52Q37275277-F694B088-1D5C-4EC2-BF25-EFFF3D8C2EC0Q37349982-7C1325B8-FA19-4702-B535-E438091F583AQ37366254-8560A011-4199-4991-9DDC-C1A3CF3584C2Q37532971-9B0DC57C-B7A7-4549-A452-D87C25F254AEQ38025441-09601BD0-10A4-4B8B-8540-43F188445C96Q39155858-F95670DA-0FC3-4563-AD44-C688CCE72866Q40245636-20ADA59D-E495-4C99-880D-F7B16F73861BQ41464970-F4E36882-AEE5-4A73-A172-AC27B517C170Q43809141-8C478614-2879-4814-B7DC-947F3B79C27EQ45381353-C41150CD-109E-4B56-98B1-782FC1BAEB62Q46942548-350968EC-7294-4B77-8377-9A9AE1A1B7D0Q48037513-002A494B-C17B-4305-ADF7-99409345AC76Q50143000-27AD764B-9264-441F-A251-D5C994D75E47Q50184931-9E9630EF-13A8-45C5-87D5-78EBD022C174
P2860
Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Prevalence and characteristics ...... ent substance abuse treatment.
@en
Prevalence and characteristics ...... ent substance abuse treatment.
@nl
type
label
Prevalence and characteristics ...... ent substance abuse treatment.
@en
Prevalence and characteristics ...... ent substance abuse treatment.
@nl
prefLabel
Prevalence and characteristics ...... ent substance abuse treatment.
@en
Prevalence and characteristics ...... ent substance abuse treatment.
@nl
P2093
P2860
P356
P1476
Prevalence and characteristics ...... ent substance abuse treatment.
@en
P2093
Anne Griffin
Katherine E Watkins
Patricia Ebener
Sarah B Hunter
Susan M Paddock
P2860
P304
P356
10.1081/ADA-200037538
P577
2004-11-01T00:00:00Z